Menu
  • Home
  • London Exchange
  • Euronext
  • Australian Exchange
  • Wire
  • Contact Us
  • Business & Finance
NewsnReleases

GE Healthcare’s Voluson SWIFT receives 510(k) clearance from the FDA

Posted on October 30, 2020October 24, 2023
GE Healthcare's Voluson SWIFT receives 510(k) clearance from the FDA 1

LONDON: Intelligent Ultrasound, the artificial intelligence (AI) based ultrasound software and simulation company, announced that GE Healthcare’s Voluson SWIFT ultrasound machine that incorporates GE Healthcare’s SonoLyst software with Intelligent Ultrasound’s ScanNav Assist AI technology, has received 510(k) clearance from the FDA for sale in the USA.

SonoLyst is the world’s first fully integrated AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging and features two applications that leverage Intelligent Ultrasound’s technology, SonoLystIR and SonoLystX.

SonoLystIR performs automated detection of the key scanning views and automated selection of the relevant Voluson SonoBiometry measurement tools; and SonoLystX, a virtual on-board ultrasound expert, uses AI to compare the acquired image to standardised criteria, to ensure that it meets clinical standards. SonoLystX can help enhance accuracy and quality and is ideal for teaching, training and quality assurance to ensure the highest quality image standards and consistency.

SonoLyst is the first AI software to be launched under the Group’s long-term licence and co-development agreement with GE Healthcare that enables the integration of Intelligent Ultrasound’s real-time AI image analysis software into GE Healthcare’s Voluson women’s health ultrasound portfolio. The first royalty per unit revenues for Intelligent Ultrasound are expected at the start of 2021.

Nicholas Sleep, CTO of Intelligent Ultrasound, said: “SonoLyst is an exciting new scanning aid in women’s healthcare and FDA clearance for the Voluson SWIFT opens up the important US market. We are delighted to be working with GE Healthcare to bring the latest AI innovations to the global ultrasound market.”

Intelligent Ultrasound (AIM: MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market.

www.intelligentultrasound.com

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Track all markets on TradingView

Investing.comThe Exchange Rates are powered by Investing.com.

Site Navigation

  • Home
  • Listed Companies
  • Contact Us
  • London Stock Exchange
  • Singapore Exchange
  • Canadian Exchange
  • Australian Exchange
  • Oslo Bourse
  • PSX
  • Ratings
  • Euronext
  • MENA
  • Nasdaq Nordic
  • Wire
  • Business & Finance
  • Gadget Reviews
  • About Us: A Comprehensive Financial News Database

All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.

Listed Companies

Equity Markets and Stock Exchanges

NNR
©2025 NewsnReleases | WordPress Theme by Superb WordPress Themes